Loading...
•
Dec 31, 2024
The Joint Q4 2024 Earnings Report
The Joint Corp. reported higher revenue and improved profitability in Q4 2024.
Key Takeaways
The Joint Corp. posted a 14% revenue increase in Q4 2024, reaching $14.4 million. System-wide sales grew by 9%, while comp sales rose 6%. The company reported net income of $986,000, a significant turnaround from the prior year’s net loss. The business continued to focus on franchising and operational efficiency, leading to improved Adjusted EBITDA of $2.1 million.
Total revenue increased by 14% to $14.4 million in Q4 2024.
Net income improved to $986,000 from a loss of $10.2 million in Q4 2023.
System-wide sales grew 9% to $145.2 million.
Comparable sales increased 6%, showing stronger operational performance.
The Joint
The Joint
Forward Guidance
The Joint Corp. anticipates continued growth in system-wide sales, comp sales, and franchising in 2025.
Positive Outlook
- System-wide sales projected to reach $550M-$570M in 2025.
- Comp sales expected to remain in the mid-single-digit growth range.
- Plan to open 30-40 new franchised clinics in 2025.
- Refocusing on franchising to enhance operational efficiency.
- Continued investment in digital marketing and patient engagement.
Challenges Ahead
- Revenue expected to decline temporarily due to refranchising efforts.
- Operational restructuring may result in short-term costs.
- Competitive pressures in the chiropractic care industry remain high.
- Macroeconomic factors could impact consumer demand for healthcare services.
- Ongoing regulatory changes may affect business operations.